Picture supply: Getty Photographs
S&P/ASX 200 Index (ASX: XJO) shares closed the session on Wednesday down 0.78% to 7,257.1 factors.
With the official reporting season now over, we have a look at 10 ASX 200 shares that brokers say are a purchase following their earnings updates.
10 ASX 200 shares impressing the consultants
Accent Group Ltd (ASX: AX1)
Morgans raised its ranking on this ASX 200 retail share so as to add, with a 12-month worth goal of $2.40. The footwear retailer reported a web revenue after tax (NPAT) of $89 million for the 53 weeks ending 2 July, up 182% on FY22. The Accent share worth closed at $2.03, down 0.49%, yesterday.
For Physician Ltd (ASX: PME)
Goldman Sachs retained its purchase ranking and upped its 12-month worth goal from $76 per share to $80 per share following the medical imaging firm’s FY23 report. Professional Medicus revealed a 36.5% bump in NPAT in FY23 to $60.5 million. The Professional Medicus share worth fell 0.27% on Wednesday, closing at $72.96.
JB Hello-Fi Restricted (ASX: JBH)
JP Morgan raised its ranking on this ASX 200 electronics and leisure retailer to chubby with a 12-month share worth goal of $52 per share. JB Hello-Fi reported an NPAT of $524.6 million in FY23, down 3.7%. The JB Hello-Fi share worth closed at $45.74 yesterday, down 0.18%.
NIB Holdings Restricted (ASX: NHF)
Goldman additionally has a purchase ranking on this ASX 200 insurance coverage share and a 12-month worth goal of $8.75. This follows NIB’s full-year report during which it revealed a 43% improve in NPAT at $191 million. This resulted in one of many largest dividend boosts of the season for buyers. NIB shares closed at $7.76, down 2.39%.
Tremendous Retail Group Ltd (ASX: SUL)
Morgans has a purchase ranking on this ASX 200 retail share with a 12-month worth goal of $15. The proprietor of BCF, Insurgent, and Tremendous Low-cost Auto reported report gross sales and an 11% surge in NPAT to $263 million in FY23. To not point out a 60% bump to its closing dividend at 60 cents per share. Tremendous Retail shares completed the session down 0.78% to $12.80 on Wednesday.
CSL Restricted (ASX: CSL)
Citi retained its purchase ranking on CSL shares with a barely cheaper price goal of $325 per share. CSL reported a 20% improve in web revenue after tax earlier than amortisation (NPATA) in fixed foreign money phrases at US$2.86 billion for FY23. The CSL share worth lifted 0.13% on Wednesday, closing at $271.20.
Allkem Ltd (ASX: AKE)
Goldman Sachs retained its purchase ranking on this ASX 200 mining share with a 12-month worth goal of $17.20. The lithium miner reported a bunch NPAT of US$525 million from persevering with operations, up 57% on FY22. The Allkem share worth closed at $14.11, down 0.84% for the day.
Lovisa Holdings Ltd (ASX: LOV)
Morgans has an add ranking on this price range jewelry chain with a 12-month worth goal of $27.50. Lovisa reported an NPAT of $68.2 million in FY23, up 16.7% on FY22. The Lovisa share worth closed at $20.94 at present, down 4.43%.
Polynovo Ltd (ASX: PNV)
Morgans raised its ranking on this ASX 200 healthcare share to purchase with a 12-month worth goal of $1.88. Polynovo reported a 58.8% improve in income in FY23 and a web loss after tax of $4.93 million. The Polynovo share worth fell 1.85% on Wednesday, closing at $1.325.
NextDC Ltd (ASX: NXT)
Goldman Sachs has a purchase ranking on this ASX 200 tech share with a 12-month worth goal of $15.80. The corporate reported report earnings earlier than curiosity, taxes, depreciation, and amortisation (EBITDA) of $193.7 million, up 15% yr over yr for FY23. The NextDC share worth closed at $13.06, down 1.36%.
